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Abstract
Introduction: spinal muscular atrophy patients present muscle weakness, orthopedic problems,
nutritional complications and respiratory impairment. Lean mass and fat mass modifications are
also expected in this population. Objective: to verify the body composition and chest expansion of
type II and III spinal muscular atrophy patients. Methods: fourteen individuals were evaluated:
seven patients in Group I of 9 (7-12) years of age, weighing 29.7 (23.5-60.0) kg; and seven children
without the disease in Group II of 9 (9-12) years, weighing 31.0 (27.8-54.1) kg. Patients’
monofrequency bioelectrical impedance was used for analyze body composition. Chest, hip and
abdominal girths were measured by a flexible steel tape. The SPSS program was used to statistical
analysis (p < 0.05). Results: patients presented higher impedance: 1416.9 (850.5-1559.1) vs
788.0 (683.6-853.8), P < 0.05; and fat percentage: 31.2 (23.9-46.6) vs 19.1 (14.9-27.0)%, P < 0.05.
The difference between forced inspiration and forced expiration thorax girth was smaller for patients
when comparing to Group II: 3.0 (0.8-4.4) vs. 5.0 (3.9-6.5) cm, P<0.05. Conclusions: patients
with spinal muscular atrophy presented higher adiposity and lower chest expansion.
Key words: neuromuscular diseases; electric impedance; body fat distribution; anthropometry;
lung.
INTRODUCTION
Spinal muscular atrophy (SMA) is a reces-
sive, autosomal neuromuscular disease character-
ized by degeneration of anterior horn spinal cord
motor cells and brain stem neurons1-5. It is classi-
fied by disease severity and the age at on set of
symptoms, namely type I for the most severe cases
and type IV for those presenting few complica-
tions1,3,6-8. Type II SMA infants get to three point of
sitting independent and present thoracic deformity
because of muscle weakness, whide causes pos-
tural deviations. Type III SMA onset occurs in older
children. Patients with type III get to three point of
walking, wether or not they maintain this ability
throughout adulthood1-3,6,7. SMA patients present
progressive symmetrical proximal weakness and
hypotonia1-4,6,8, but there is no sensory abnormal-
ity7. Besides muscle weakness, respiratory9, ortho-
pedic5, and nutritional10-12 problems are particularly
note wortley.
Among the methods used to evaluate body
composition in children, bioelectrical impedance
stands out as a noninvasive and painless method,
which has already been adopted by other authors
while evaluating SMA patients13, or children and
adolescents without the disease14-16. Body girth
measurements are frequently used in clinical prac-
tice17,18 due to their practical character and low price.
Thoracic girth has already been associated with
pulmonary function19, without any intention of
replacyng the standard spirometry measurements,
used for a more frequent follow up of patients’ pul-
monary function.
SMA children suffer from stunted develop-
ment due to nutritional, muscular, postural and res-
piratory alterations. Body composition assessment
in these patients is proposed by Caromano et al.20,
since they state that there is a correlation between
fat percentage and muscle strength in neuromus-
cular patients. There are few studies assessing neu-
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romuscular patients with more specific methods
than bioelectrical impedance and anthropometric
measurements. Therefore, the aim of this study is
verify the body composition and chest expansion
of type II and III spinal muscular atrophy patients.
METHODS
Study Protocol and Sample
Seven SMA patients (five with type II and
two with type III) were recruited (Group I) from
the neuropediatric outpatient clinic of the Institute
of Child Health and Pediatrics Martagão Gesteira
(IPPMG), Federal University of Rio de Janeiro (UFRJ)
and were evaluated at the Postgraduate Program
of Rehabilitation Sciences laboratories, Augusto
Motta University Center (UNISUAM). To compare
data, seven individuals without the disease (Group
II, control) had already participated in a previous
research project at UNISUAM were selected from
Rui Barbosa School (Bonsucesso – Rio de Janeiro,
RJ), who had their age, sex, weight and height char-
acteristics being paired with those of the patients
(Table 1).
Assessments
Weight
Total body mass measurement was performed
with an analog scale (R110, Welmy - Santa Bárbara
d’Oeste, São Paulo, Brazil) to the nearest 0.1 kg.
The subject was instructed to maintain both feet
on the platform, without support and with the en-
tire weight divided between both lower limbs21. For
those that could not maintain the upright posture,
this measurement was done with another person’s
help (supporting the patient) and subtracting the
weight of the assistant from the total weight mea-
sured.
Height
Height was estimated for all participants
(Groups I and II) by the equation proposed in the
literature for Brazilian data22 because a great num-
ber of patients could not stand up and had lower
limb deformities:
Height (cm) = 63.525
3.237* (S)-0.06904* (A)+1.293*(HS)
Where S = sex (boys = 1; girls = 2); A = age
(years) and HS = half span (cm, distance between
the sternum and the distal phalange of the third
finger, with the flexible steel tape parallel to the
clavicle23).
Bioelectrical Impedance
Body composition analysis was performed
using a monofrequency bioelectrical impedance ana-
lyzer (BIA 310e, Biodynamics, Seattle, Washington,
USA). Two electrodes were applied to the dorsal sur-
face of the right hand and two electrodes were placed
on the dorsal surface of the right foot. The exam
was performed in the supine position and the sub-
jects received standardized recommendations: 1) no
alcohol consumption or exercise within 24 hours prior
to the test; 2) no caffeine or food consumption for
four hours prior to the test; 3) the consumption of
two-four glasses of water within the two hours prior
to the test; 4) bathroom use within the 30 minutes
prior to the assessment. Resistance and reactance
values provided by the analyzer were used to esti-
mate the fat-free mass (kg), in a child-specific equa-
tion14,15: FFM = 2.33 + 0.588*(H2/I) + + 0.211*W,
where FFM = fat-free mass (kg);
H = height (cm); I = impedance (Resistance2 + + Re-
actance2)1/2 (W); W = weight (kg)14. Fat percentage
was calculated by the following equations:
FM = W – FFM; and %F = (FM/W)*100, where FM =
fat mass (kg), W = weight (kg), FFM = fat-free mass
(kg), and % F = fat percentage (%).
Additionally, body mass index (BMI = W/H2),
fat-free mass index (FFMI = FFM/H2) and fat mass
index (FMI = FM/H2) were calculated as previously
described11.
Girths
A flexible steel tape (Terrazul, Cambuci, São
Paulo, Brazil) was used to measure the body girths.
The abdomen measurement was made at umbilical
level 24 and the hip girth, at the greatest girth, proxi-
mately to pubic symphysis21. For those that could
not maintain the upright posture, measurements
were taken with another person’s help, supporting
the patient’s weight while the examiner performed
the measurement. For thoracic girth, the flexible
steel tape was placed at the level of the mesoster-
num, with arms abducted21. For those that could
not maintain posture, the measure the upright was
performed in a sitting position, preferentially with-
out the use of chair back. Three measure were
taken: 1) standard after a normal expiration (Tho-
rax)21; 2) maximal inspiration after a forced inspi-
ration (ThoraxInsp); and 3) maximal expiration af-
ter a forced expiration (ThoraxExp). The difference
between maximal inspiration and maximal expira-
tion girths was called ‘chest expansion’.
Ethical Aspects
Informed consent was obtained from the
childrens’ parents and the protocol was approved
by UNISUAM Ethics Committee before being applied
(CAAE: 0028.0.307.000-11).
Statistical Analysis
Nonparametric descriptors and tests with
resampling methods were selected because of the
small sample size. Data were expressed as me-
dian (interquartile range). The Mann Whitney U
test was used to compare groups, and the Monte
Carlo simulation with 10,000 bootstrap samples
was applied. All analyses were realized on the SPSS
program, version 13.0, considering a 5% level of
significance.
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RESULTS
Table 1 summarizes demographic, body com-
position and girth variables separated by group. The
age of Group I was 9 (7-12) years old, similar to
Group II: 9 (9-12) years old (P = 0.509). The groups
were also comparable for weight, height and BMI:
29.7 (23.5-60.0) vs. 31.0 (27.8-54.1) kg,
P = 0.618; 1.45 (1.40-1.58) vs. 1.55 (1.45 -
- 1.63) m, P = 0.262; and 15.3 (9.8 - 21.3) vs.
14.0 (12.9-18.8) kg/m2, P = 0.905, respectively.
Group I presented higher values of resistance,
impedance and fat percentage. Lower values of
chest expansion, fat-free mass and FFMI were also
observed, though the last two variables presented
no statistical difference (Table 1, Figure 1).
Table 1: Demographic, body composition and girth variables
Variables/Groups Group I (n = 7) Group II (n = 7) P-value*
Half span (cm) 65.1 (60.3-77.0) 74.0 (66.0-80.0) 0.171
Resistance (W) 1416 (850-1557) 785 (681-849) 0.005
Reactance (W) 51 (43-68) 60 (54-70) 0.267
Impedance (W) 1416.9 (850.5-1559.1) 788.0 (683.6-853.8) 0.008
FM (kg) 9.3 (5.7-27.7) 5.3 (4.6-13.7) 0.320
FMI (kg/m2) 5.4 (2.7-11.1) 2.6 (1.9-4.8) 0.169
FFM (kg) 20.3 (16.0-26.7) 26.4 (24.2-33.6) 0.055
FFMI (kg/m2) 9.5 (7.1-11.9) 12.1 (10.9-12.9) 0.055
Thorax (cm) 64.2 (56.5-79.1) 63.2 (60.5-78.5) 0.624
ThoraxInsp(cm) 69.0 (60.3-86.8) 67.1 (66.0-79.0) 0.757
ThoraxExp (cm) 63.5 (56.1-78.1) 63.2 (59.5-77.5) 0.624
Chest Expansion (cm) 3.0 (0.8-4.4) 5.0 (3.9-6.5) 0.049
Abdomen (cm) 60.5 (49.9-82.3) 60.7 (57.0-75.0) 0.945
Hip (cm) 72.0 (60.0-80.6) 70.5 (66.0-81.0) 0.811
Data are expressed as median (interquartile range). * Mann-Whitney U Test, with Monte Carlo simulation.
FM = fat mass; FMI = fat mass index; FFM = fat-free mass; FFMI = fat-free mass index; Thorax = thorax girth after
a normal expiration; ThoraxInsp = thorax girth after a forced inspiration; ThoraxExp = thorax girth after a forced
expiration.
 
* 
Figure 1: Groups I and II fat percentage box plot (minimum, 1st quartile, median, 3rd quartile and maximum).
*P < 0.05 (Mann Whitney U test, with Monte Carlo simulation).
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DISCUSSION
Group I composed of SMA patients exhibited
higher body adiposity (with both high impedance
and body fat percentage) than Group II. Leroy-Willig
et al.25 applied magnetic resonance and anthropo-
metric measures to study the body composition of
11 children with neuromuscular diseases. Those au-
thors observed an average of 35.9% of fat (skinfold
thickness method), similar to the median values of
the present study (31.2%). However, those authors
included only three patients with SMA type II and
did not investigate the thoracic expansion of their
sample.
Higher values of body fat percentage and FMI
as compared to regional normative data (paired by
sex, age, and ethnic data) in the United States were
also observed in 25 types I, II, and III SMA pa-
tients11. Another American research group13  showed
that 21 patients with types II and III SMA have
higher levels of adiposity than subjects without the
disease, considering either the thickness of subcu-
taneous fat tissue or the use of multifrequency bio-
electric impedance. In agreement with this study,
subcutaneous fat evaluated by a skinfold thickness
caliper in 25 SMA patients (type II: 15; type III: 10
patients) was higher (type II: 12.5 mm; type III:
8.82 mm) than that of individuals without the dis-
ease (average of 5.37 mm) in the United States26.
A study from Rio Grande do Norte, Brazil27,
assessed the fat percentage in 25 patients with
neuromuscular diseases but presented results which
cannot be compared with ours. In that study, 48%
of the sample presented with optimal values, the
remainder being  categorized as ‘low’ and ‘very low’.
However, used the different method for assessment
of fat percentage between these studies (skinfold
thickness technique vs bioelectric impedance analy-
sis) must be falceer into consideration, as well as
the fact that only four SMA patients were included
in the heterogeneous group of patients with neuro-
muscular diseases.
In a recent update, Markowitz et al. 3 stated
that SMA patients have excessive fat mass in re-
lation to their muscle mass even for patients with
normal BMI, as observed in our Group I. This fact
may suggest to the nutritional health professional,
who may assess the SMA patient only by BMI, to
prescribe a dietary program to increase weight6
that he should this reinforcing the fat accumula-
tion in this population. These findings justify the
use of more precise measures of body composi-
tion in SMA patients. Overweight occurs mainly
in type II, III, and IV6 SMA patients because type
I patients present bulbar complications which
cause an abrupt reduction of body weight (e.g.,
swallowing difficulties). The physiological process
by which the fat accumulates in this population is
not yet clear, a possible hypothesis being the re-
placement of myocytes by both conjunctive and
adipose tissue in advanced stages of this chronic
disease.
The fat-free mass in Group I was lower
through without statistical significance than in
the healthy group . This small amount of muscle
mass corroborates the clinical profile of weak-
ness observed in SMA patients1-4,6,8. A recent Bra-
zilian study27 reported that 90% of the patients
exhibited severe depletion of muscle reserve, in
agreement with our results. The fact that these
patients present low levels of physical activity
due to muscle weakness and contractures rein-
forces the low energetic expenditure and the risk
of obesity6. The increased fat mass represents
an additional threat to the already compromised
muscles that may lead to diminished motor func-
tion11.
It is worth noticing that the height as esti-
mated from the equation used in this study14 was
used to calculate the fat-free mass suggested by
Rabito et al. 22. Those authors observed a coeffi-
cient of determination equal to 0.88 and consid-
ered this value between very good and excellent28,
suggesting that it was a valid strategy to apply
this formula to all subjects (including those that
could stand up for measurement of height). There
is a consensus in the literature concerning the
difficulties in obtaining accurate height measure-
ments due to muscle contractures or inability to
stand up, the use of measurements of other body
segments and the half span (as in the present
study) being suggested to estimate the patient’s
height6. The average arm span of three SMA pa-
tients was 140 cm in a previous study25 and is
similar to the double of the median half span ob-
served in the present study (67.87 cm x 2
= 135.74 cm).
Data from a previous study29 on pulmonary
function (spirometry) in SMA patients showed a
restrictive disorder characteristic of this popula-
tion as resulting from respiratory muscle weak-
ness, and reduced both chest wall and pulmonary
compliance. Small values of thoracic expansion in
the studied sample confirm this respiratory restric-
tion and show that assessments by a simple in-
strument (such as a flexible steel tape) can be
used for the follow-up of pulmonary function. Ac-
cording to Lima and Lima30, girth measurements
in children are important since it is a simple
method, thus allowing the follow-up of bodily di-
mensions in clinical practice. A characteristic fea-
ture of type II SMA patients is the major weak-
ness of the intercostal muscle, in addition to
weakness of the other inspiratory and expiratory
muscles6. The observed difference in thoracic ex-
pansion for Group I corroborates the above-cited
relationship in a recent review about SMA3, when
the respiratory muscle weakness, the restrictive
pulmonary function, and the natural history of dis-
ease are considred.
In conclusion, type II and III SMA patients
present higher adiposity and lower thoracic expan-
sion as compared to a paired sample without the
disease.
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